Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Vaccinia virus(VACV) L1R/Protein L1 Antibody (M12B9)

Catalog #:   RVV13902 Specific References (11) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, Neutralization
Overview

Catalog No.

RVV13902

Species reactivity

Vaccinia virus(VACV)

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Protein L1, Virion membrane protein M25, VACWR088, L1R

Concentration

1.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

M12B9

Data Image
References

Enhanced Expression of the L1R Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine., PMID:39460282

L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines., PMID:23578094

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization., PMID:19257896

Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans., PMID:19162289

Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge., PMID:18524827

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies., PMID:18485547

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine., PMID:18234801

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein., PMID:17688903

Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells., PMID:17553539

Human T-cell responses to vaccinia virus envelope proteins., PMID:17005679

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions., PMID:15367588

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Vaccinia virus(VACV) L1R/Protein L1 Antibody (M12B9) [RVV13902]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only